Rein Therapeutics, Inc. · NASDAQ:RNTX
LYTTON LAURENCE W reported a 5.80% stake in Rein Therapeutics, Inc. (Schedule 13G)
Event May 1, 2026 · Filed May 6, 2026
LYTTON LAURENCE W reported a 5.80% stake in Rein Therapeutics, Inc., 4,500,000 shares, as a passive investor on May 1, 2026. Filed May 6, 2026 (Schedule 13G).
- Stake
- 5.80%
- Shares
- 4,500,000
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| LYTTON LAURENCE W | 5.80% | 4,500,000 |
Source
Related
- Rein Therapeutics, Inc.
- Laurence W. Lytton
- Rein Therapeutics, Inc. shareholders
- Schedule 13G/A · Laurence W. Lytton · Aug 13, 2026
- Schedule 13G/A · Lynwood Capital Management Inc. · Aug 14, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Voss Capital, LP · Jul 14, 2026
- Form 4 · Von Rickenbach Josef H · May 28, 2026
- Form 4 · Windsor James Brian · May 13, 2026